- RFK Jr.’s vaccine committee advises Merck’s RSV shot for babies NewsNation
- RFK Jr’s vaccine panel recommends new RSV treatment for infants The Guardian
- ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season Merck.com
- RFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants CNBC
- ACIP’s New Class Endorses RSV, Talks COVID Medscape
Source link
